Table 2.

Results of the Chi-squared tests on the clinical descriptors of the CAMDA 2017 neuroblastoma dataset

	Gender	Age	MYCN	Risk	Stage	Prog	Death
Gender		1	1	1	1	1	1
Age	0.61		5.3e-4	8.8e-28	1.6e-19	3.6e-7	4.8e-11
MYCN	0.50	2.5e-5		3.2e-44	7.4e-11	2.3e-8	8.2e-17
Risk	0.09	4.2e-29	1.5e-45		1.7e-57	3.4e-25	1.6e-34
Stage	0.43	7.7e-21	3.5e-12	8.2e-59		4.2e-21	1.9e-21
Prog	0.58	1.7e-8	1.1e-9	1.6e-26	2.0e-22		1.2e-49
Death	0.37	2.3e-12	3.9e-18	7.5e-36	9.0e-23	5.5e-51

Results are presented for all pairwise comparisons with Bonferroni corrected P values in the upper triangle, and uncorrected P values in the lower triangle. Notes: Age: age at diagnosis, MYCN: MYCN mutation status, Risk: high-risk, Stage: INSS tumor stage, Prog: progression, Death: death from disease